Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.

Fragment-Based Lead Discovery and Design

Joseph-McCarthy, Diane, Campbell, Arthur J., Kern, Gunther, Moustakas, Demetri · 2014 · Journal of Chemical Information and Modeling

Abstract

Fragment-based lead discovery and design has and continues to show increasing promise in drug discovery. In this article, the current state of the art in terms of hot-spot characterization, fragment screening techniques, and fragment-based design is discussed. Three overall fragment-based lead generation strategies are explored and involve the chemical biology characterization of biological targets via fragment screening, fragment screening as a complementary approach to high-throughput screening of drug-like compounds, and direct fragment-based drug discovery, respectively. The evolution and development of fragment libraries is described. With an emphasis on computational approaches and the strategies applied at AstraZeneca, the review illustrates how integration of data from one regime can inform the design of experiments in the other, ultimately leading to the discovery of high quality chemical matter.

Overview

Integrity signals

Registry

Crossref · 10.1021/ci400731w

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 114 references

Research works printed but not linked: 6

  1. Joseph-McCarthy D., 2007, Curr. Opin. Drug Discov. Devel., 10, 264
  2. Cavanagh, J.; Fairbrother, W. J.; Palmer, III, A. G.; Skelton, N.; Rance, M.Protein NMR Spectroscopy: Principles and Practice;Elsevier Science & Technology:Oxford/GB, 2006; p912.
  3. Bartoli S., 2007, Curr. Opin. Drug Discov. Devel., 10, 422
  4. Rawlins P., 2010, Drug Discov. World
  5. Davies T. G., 2011, Top. Curr. Chem., 1
  6. Nilakantan R., 2002, Comb. Chem. High Throughput Screen., 5, 105

Cited by

Metadata

Authors
Joseph-McCarthy, D., Campbell, A. J., Kern, G., & Moustakas, D.
Affiliations
  • Infection Innovative Medicines Unit, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States
  • AstraZeneca (United States) (US)
Venue
Journal of Chemical Information and Modeling
Published
2014-02-19
Volume
54
Issue
3
Pages
693-704
ISSN
  • 1549-9596 (ISSN-L)
  • 1549-960X
OpenAlex
W2090936831
Cited by
129
References
114
Citations by year
2026: 1 · 2025: 1 · 2024: 8 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 11 · 2019: 15 · 2018: 12 · 2017: 19 · 2016: 22 · 2015: 17 · 2014: 7
FWCI
1.87
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Chemical Information and Modeling (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Keywords
fragment-based drug discovery, fragment screening, fragment libraries, chemical biology, high-throughput screening, computer-aided drug design, AstraZeneca
MeSH terms
Animals, Humans, Magnetic Resonance Spectroscopy, Proteins, Crystallography, X-Ray, Surface Plasmon Resonance, Small Molecule Libraries, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.